Semax or selank as an Adderall replacement: what the evidence says

What did @rivi.rl actually say?

The creator claims they swapped Adderall ("Prattle" in the transcript, clearly a speech-to-text error) for Semax, calling it a game-changer for ADHD symptoms. They argue Adderall is "one of the worst things you can take for your mind," that it makes you "lose your personality" and kills dopamine enjoyment. Their conclusion: Semax is "a lot healthier" and carries "zero dopamine risk."

To be fair about what we're working with here: the transcript is badly garbled, likely from auto-captioning. "Some accent" and "Celine" appear to be Semax and Selank respectively. The core argument is still readable though. They're positioning a research peptide as a cleaner, safer substitute for a Schedule II stimulant prescribed for a clinical condition. That's a claim worth scrutinizing carefully.

Does the science back this up?

Not in any meaningful clinical sense. Semax has legitimate research behind it, mostly from Russian studies, but nothing that supports replacing a prescribed ADHD medication with it. The evidence base is thin, small-scale, and largely not replicated in Western peer-reviewed literature.

Semax is a synthetic heptapeptide derived from ACTH(4-7). It has been studied primarily in Russia for cognitive enhancement and stroke recovery. Some animal studies and small human trials suggest it increases BDNF (brain-derived neurotrophic factor) and modulates dopaminergic and serotonergic systems (Dolotov et al., 2006, Journal of Neurochemistry). A 2011 study by Lebedeva et al. in the Russian journal Eksperimental'naya i Klinicheskaya Farmakologiya found some attention-related benefits in children with intellectual disabilities, not ADHD specifically. There are no randomized controlled trials comparing Semax to amphetamine salts for ADHD. The creator's claim of "zero dopamine risk" is especially unsupported. Semax appears to modulate dopamine pathways, which means the risk profile is unknown, not absent.

What did they get wrong (or right)?

They got a few things partially right and several things wrong. Credit where it's due: Adderall does carry real risks for some users. Personality blunting, anhedonia, and reduced spontaneity are documented side effects of long-term amphetamine use, particularly at higher doses (Berman et al., 2009, Drug and Alcohol Dependence). The experience they describe is real and reported by many patients.

What they got wrong is bigger. Describing Semax as carrying "zero dopamine risk" is flatly inaccurate. Any compound that modulates dopaminergic signaling carries some profile of dopamine-related effects, and Semax does interact with those pathways (Dolotov et al., 2006). More importantly, framing this as a straightforward swap for ADHD treatment ignores that Adderall is a regulated medication prescribed for a diagnosed condition. Semax is not FDA-approved for any indication. It is not tested for safety or efficacy in ADHD populations in large-scale trials. Telling viewers with ADHD symptoms to try Semax instead of a prescribed medication is medically irresponsible, regardless of their personal experience.

What should you actually know?

Semax is a research peptide with an interesting but underdeveloped evidence base. It is not a proven ADHD treatment, and it is not a safe or validated substitute for prescribed stimulant medications.

Here is what the actual clinical picture looks like. Semax is not FDA-approved. It exists in a legal gray area in the United States, where it is sometimes sold as a research chemical. Quality control across suppliers is inconsistent, meaning what you buy may not contain what the label claims. It has not been studied in long-term human trials for cognitive enhancement or ADHD. If you are experiencing side effects from Adderall, the medically appropriate step is to talk to your prescribing provider. Non-stimulant options like Strattera (atomoxetine) or Intuniv (guanfacine) exist within the regulated system and have actual clinical trial data behind them. Anecdotal TikTok reports, even genuinely experienced ones, are not a substitute for that evidence base. The risks of stopping a prescribed ADHD medication without guidance include worsening attention, impulsivity, and occupational or academic consequences.

• Semax has been studied primarily in Russia with small samples and limited independent replication.
• No trial has compared Semax to amphetamine salts for ADHD outcomes.
• "Zero dopamine risk" is not a scientifically supportable claim for any dopamine-modulating compound.
• Adderall side effects are real and documented, but the solution is a conversation with a prescriber, not a peptide from an unregulated supplier.